Drugmaker Merck & Co. Inc. sued the federal government Tuesday, seeking an injunction against parts of last year’s reconciliation law that allow the Health and Human Services Department to ...
Merck sued the U.S. government on Tuesday (June 6), seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act (IRA), which it argues is violates the ...
Merck’s lawsuit is one of several cases filed across the country challenging the constitutionality of the IRA drug negotiation program. As the government’s summary judgment motion and supporting amici ...
Anglo-Swedish group is latest to challenge Medicare’s new power to negotiate prices for a limited number of medicines ...
(Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure ...
Merck sued the U.S. government on Tuesday (June 6), seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act (IRA), which it argues is violates the ...
Sept 1 (Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart ...
Novartis has become the latest drugmaker to sue the US government over the Medicare drug price negotiation element of President Biden’s Inflation Reduction Act (IRA). The lawsuit, filed in federal ...
(Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure ...
(Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure ...
Sept 1 (Reuters) - Swiss drugmaker Novartis NOVN.S on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling ...
(Reuters) - Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which includes its top-selling heart-failure ...
